Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Same active ingredient, same dose, different delivery system
As of April 2025, retatrutide is not approved for clinical use in the United Kingdom
AARDEX is the only mature, robust and proven adherence solution on the market today, one that maximises the reward, mitigates the risk and delivers resolution for your clinical trial
Data from Rediger et al
IGF-1 LR3 is a significantly more potent derivative of native IGF-1 (insulin-like growth factor-1)
US$ 23.13
US$ 22.44
US$ 20.52
US$ 23.12
US$ 23.62
US$ 24.43
US$ 25.04
US$ 22.96
US$ 23.38
US$ 23.77
